Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03605498 · ClinicalTrials.gov registry record

OR PathTrac (Tracking Intra-operative Bacterial Transmission)

A clinical trial of Bacterial Infections, sponsored by Sundara Reddy.

Completed
Registry status
83
Enrollment target
1
Study location

NCT03605498: Completed study of Bacterial Infections, sponsored by Sundara Reddy.

NCT03605498 is a study of Bacterial Infections that has completed, run by Sundara Reddy. The registered enrollment target is 83 participants, below the 136-participant average among 17 other Bacterial Infections trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03605498, a study of Bacterial Infections, has completed, sponsored by Sundara Reddy.

COMPLETED
Registry status
83 participants
Enrollment target
1
Study location

Study Summary

Healthcare-associated infections occur frequently and are associated with patient harm. These infections are becoming more difficult to treat due to antibiotic resistance. It is important that healthcare facilities take the steps necessary to prevent the spread of resistant bacteria between patients.

Primary Outcome

Focus on how Staph aureus is transmitted in the operating room by identifying key areas of origin.

Conditions Studied

Bacterial Infections

Study Locations (1)

Iowa

  • University of Iowa Hospitals and Clinics - Iowa City

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2017-09-05
Est. Completion 2018-02-12
Sundara Reddy

2 total trials

What the finished NCT03605498 record still lists

NCT03605498 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 136-participant average among 17 other Bacterial Infections trials with a reported enrollment target (39% lower).

The record links to 1 condition, with Bacterial Infections appearing as the primary indexed condition, and to 0 interventions.

NCT03605498 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT03605498 about?

NCT03605498 is a clinical study titled "OR PathTrac (Tracking Intra-operative Bacterial Transmission)". Healthcare-associated infections occur frequently and are associated with patient harm. These infections are becoming more difficult to treat due to antibiotic resistance. It is important that healthcare facilities take the steps necessary to prevent the spread of resistant bacteria between patients...

What is the current status of trial NCT03605498?

This trial is currently completed. The enrollment target is 83 participants. The study started on 2017-09-05. Estimated completion is 2018-02-12.

What conditions does trial NCT03605498 study?

This clinical trial studies the following conditions: Bacterial Infections.

Who is sponsoring clinical trial NCT03605498?

This trial is sponsored by Sundara Reddy, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03605498 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Bacterial Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03605498's enrollment target sits among peer trials

83 6th of 17 higher than 12 of 17 other Bacterial Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bacterial Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02974647 · 83 participants · Phase 2

    Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

  • NCT03919292 · 83 participants · Phase 1

    Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

  • NCT04626674 · 83 participants · Phase 1

    A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

  • NCT05277168 · 83 participants · Phase 1

    A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03605498, the US trial registry maintained by the National Library of Medicine. NCT03605498 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.